ACCC alleges misleading representation over Voltaren pain relief gels

GSK says it's disappointed after the ACCC announced it was taking it and Novartis to court over alleged misleading representations The ACCC announced that it has instituted proceedings in the Federal Court of Australia against GlaxoSmithKline Healthcare Australia Pty Ltd and Novartis Consumer Health Australasia Pty Ltd, alleging they made false or misleading representations in